JZJiaming Zhang

Jiaming Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiaming Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Qingran Kong

    Oujiang Laboratory, Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China

    3 shared publications
  • Ming Zong

    School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China

    2 shared publications
  • Zhonghua Liu

    College of Life Science, Northeast Agricultural University, Harbin, China

    2 shared publications
  • Chun-Ming Ding

    School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China

    1 shared publication
  • Chunming Ding

    School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China

    1 shared publication
  • Guoning Huang

    Center for Reproductive Medicine, Women and Children’s Hospital of Chongqing Medical University, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Metabolic control of histone acetylation for precise and timely regulation of minor ZGA in early mammalian embryos

    by Jingyu Li, Jiaming Zhang, Weibo Hou, Xu Yang, Xiaoyu Liu, Yan Zhang, Meiling Gao, Ming Zong, Zhixiong Dong, Zhonghua Liu, et al.

    Metabolism feeds into the regulation of epigenetics via metabolic enzymes and metabolites. However, metabolic features, and their impact on epigenetic remodeling during mammalian pre-implantation development, remain poorly understood. In this study, we established the metabolic landscape of mouse pre-implantation embryos from zygote to blastocyst, and quantified some absolute carbohydrate metabolites. We integrated these data with transcriptomic and proteomic data, and discovered the metabolic characteristics of the development process, including the activation of methionine cycle from 8-cell embryo to blastocyst, high glutaminolysis metabolism at blastocyst stage, enhanced TCA cycle activity from the 8-cell embryo stage, and active glycolysis in the blastocyst. We further demonstrated that oxidized nicotinamide adenine dinucleotide (NAD+) synthesis is indispensable for mouse pre-implantation development. Mechanistically, in part, NAD+ is required for the exit of minor zygotic gene activation (ZGA) by cooperating with SIRT1 to remove zygotic H3K27ac. In human, NAD+ supplement can promote the removal of zygotic H3K27ac and benefit pre-implantation development. Our findings demonstrate that precise and timely regulation of minor ZGA is controlled by metabolic dynamics, and enhance our understanding of the metabolism of mammalian early embryos.


  • Open Access

    Argonaute 2 is a key regulator of maternal mRNA degradation in mouse early embryos

    by Jia-Ming Zhang, Wei-Bo Hou, Jia-Wei Du, Ming Zong, Kai-Lun Zheng, Wei-Jia Wang, Jia-Qiang Wang, Heng Zhang, Yan-Shuang Mu, Zhi Yin, et al.

    In mammalian early embryos, the transition from maternal to embryonic control of gene expression requires timely degradation of a subset of maternal mRNAs (MRD). Recently, zygotic genome activation (ZGA)-dependent MRD has been characterized in mouse 2-cell embryo. However, in early embryos, the dynamics of MRD is still poorly understood, and the maternal factor-mediated MRD before and along with ZGA has not been investigated. Argonaute 2 (Ago2) is highly expressed in mouse oocyte and early embryos. In this study, we showed that Ago2-dependent degradation involving RNA interference (RNAi) and RNA activation (RNAa) pathways contributes to the decay of over half of the maternal mRNAs in mouse early embryos. We demonstrated that AGO2 guided by endogenous small interfering RNAs (endosiRNAs), generated from double-stranded RNAs (dsRNAs) formed by maternal mRNAs with their complementary long noncoding RNAs (CMR-lncRNAs), could target maternal mRNAs and cooperate with P-bodies to promote MRD. In addition, we also showed that AGO2 may interact with small activating RNAs (saRNAs) to activate Yap1 and Tead4, triggering ZGA-dependent MRD. Thus, Ago2-dependent degradation is required for timely elimination of subgroups of maternal mRNAs and facilitates the transition between developmental states.


  • Endo-siRNAs regulate early embryonic development by inhibiting transcription of long terminal repeat sequence in pig†

    by Qingran Kong, Xue Quan, Jiawei Du, Yurong Tai, Wanxin Liu, Jiaming Zhang, Xiaolei Zhang, Yanshuang Mu, Zhonghua Liu

    Activity of some endogenous retroviruses (ERVs) has been proven to be important for development of early mammalian embryo. However, abnormal activation of ERVs can also cause genetic diseases due to their ability to retrotranspose, so the regulatory mechanism to limit transcription of ERVs needs to be clarified. Endogenous small interfering RNA (endo-siRNA) has been reported to protect cells against transposable elements (TEs). Here, we determined the role of ERVs long terminal repeat sequences (LTRs) derived endo-siRNAs (LTR-siRNAs) on inhibition of the activity of ERVs during early embryonic development in pig. 7 most highly expressed LTR-siRNAs were identified in porcine zygote by high-throughput small RNA sequencing. We verified that the biogenesis of the LTRs-siRNAs was DICER-dependent and they were generated from double-stranded RNA (dsRNA) formed by sense and antisense transcripts of LTRs. And, the expression of sense and antisense of LTRs might be due to the loss of DNA methylation at some LTRs locus. Furthermore, we showed that the LTR-siRNAs could regulate early embryonic development by repression of LTRs expression at a post-transcriptional level. So, we propose here, during early embryonic development when epigenetic reprogramming occurs, endo-siRNA pathway act as a sophisticated balance of regulatory mechanism for ERVs activity.